TR Biofab (Korea) Today
| 246710 Stock | KRW 3,275 65.00 2.02% |
PerformanceVery Weak
| Odds Of DistressBelow Average
|
TR Biofab is trading at 3275.00 as of the 19th of March 2025, a 2.02 percent increase since the beginning of the trading day. The stock's open price was 3210.0. TR Biofab has about a 30 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 19th of December 2024 and ending today, the 19th of March 2025. Click here to learn more.
TR Biofab Co., Ltd. researches and develops medical devices for transplantation and tissue regeneration in the areas of orthopedics, plastic surgery, and dentistry. The company was founded in 2013 and is based in Siheung, South Korea. TR Biofab is traded on Korean Securities Dealers Automated Quotations in South Korea.. The company has 8.34 M outstanding shares. More on TR Biofab Co
Moving against 246710 Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
246710 Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. TR Biofab's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding TR Biofab or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Health Care Equipment & Supplies, Healthcare (View all Sectors) |
TR Biofab Co (246710) is traded on KOSDAQ in Korea . The company currently falls under 'Mega-Cap' category with a current market capitalization of 101.49 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate TR Biofab's market, we take the total number of its shares issued and multiply it by TR Biofab's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. TR Biofab operates under Healthcare sector and is part of Health Care Equipment & Supplies industry. The entity has 8.34 M outstanding shares.
TR Biofab Co has accumulated about 23.66 B in cash with (7.56 B) of positive cash flow from operations.
Check TR Biofab Probability Of Bankruptcy
Ownership AllocationThe market capitalization of TR Biofab Co is W101.49 Billion. TR Biofab shows serious amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Note, that even with negative profits, if the true value of the company is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Check 246710 Ownership Details
TR Biofab Risk Profiles
Although TR Biofab's alpha and beta are two of the key measurements used to evaluate TR Biofab's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.6 | |||
| Standard Deviation | 4.03 | |||
| Variance | 16.23 | |||
| Risk Adjusted Performance | (0.16) |
246710 Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in TR Biofab without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Backtesting Now
Portfolio BacktestingAvoid under-diversification and over-optimization by backtesting your portfolios |
| All Next | Launch Module |
Other Information on Investing in 246710 Stock
TR Biofab financial ratios help investors to determine whether 246710 Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in 246710 with respect to the benefits of owning TR Biofab security.